Event Date/Time: May 20, 2013 / 9:00 am - (GMT) End Date/Time: May 21, 2013 / 6:00 pm - (GMT)
Report as Spam

Description

The 13th Annual Pain Therapeutics conference will showcase recent finding in areas such as: current targets for analgesic development, personalised medicine, the cannabinoid approach, imaging modalities, experimental models in early phase clinical development and improving clinical trial success rates. This promises to be a truly unmissable event!

KEY REASONS TO ATTEND

  • Balance of clinical and pre-clinical considerations alongside therapeutic applications
  • Focus on personalised medicine and translational methods aiming to develop the efficacy of drugs
  • Explore the use of anti-NGFs in the treatment of pain alongside the discovery of novel targets
  • Spotlight on translational mechanistic pain biomarkers
  • Study the use of imaging modalities such as fMRI for pain measurement
  • Network with key industry professionals and discuss the future of pain therapeutics  

KEY SPEAKERS INCLUDE:

  • Dave Shelton, Executive Director, Pfizer
  • Narender Gavva, Scientific Director, Amgen
  • Lars Arendt-Nielsen, Director, Center for Sensory-Motor Interaction, Aalborg University
  • Peter French, Chief Executive Officer, Benitec Biopharma
  • Huw Rees, Senior Principal Scientist, Pfizer
  • Steve Harrison, Vice President, Research Biology, Nektar Therapeutics
  • Stephen Arneric, Senior Research Fellow, Eli Lilly
  • Valerie Morisset, Head of Electrophysiology, Convergence Pharmaceuticals
  • Iain Chessell, Head, Neuroscience Centre of Excellence, MedImmune

Contact Cem Tuna on telephone +44 (0) 20 7827 6736

Venue